Literature DB >> 16389195

Implication of SSAT by gene expression and genetic variation in suicide and major depression.

Adolfo Sequeira1, Fuad G Gwadry, Jarlath M H Ffrench-Mullen, Lilian Canetti, Yves Gingras, Robert A Casero, Guy Rouleau, Chawki Benkelfat, Gustavo Turecki.   

Abstract

CONTEXT: A large body of evidence suggests that predisposition to suicide, an important public health problem, is mediated to a certain extent by neurobiological factors.
OBJECTIVE: To investigate patterns of expression in suicide with and without major depression and to identify new molecular targets that may play a role in the neurobiology of these conditions.
DESIGN: Brain gene expression analysis was performed using the Affymetrix HG-U133 chipset in the orbital cortex (Brodmann area [BA] 11), the dorsolateral prefrontal cortex (BA8/9), and motor cortex (BA4). Subsequent studies were carried out in independent samples from adjacent areas to validate positive findings, confirm their relevance at the protein level, and investigate possible effects of genetic variation.
SUBJECTS: We investigated 12 psychiatrically normal control subjects and 24 suicide victims, including 16 with and 8 without major depression, in the brain gene expression analysis, validation, and protein studies. The genetic studies included 181 suicide completers and 80 psychiatrically normal controls. All subjects investigated were male and of French Canadian origin. MAIN OUTCOME MEASURES: Gene expression measures from microarray, semiquantitative reverse transcription-polymerase chain reaction, immunohistochemistry, and Western blot analyses.
RESULTS: Twenty-six genes were selected because of the consistency of their expression pattern (fold change, >1.3 in either direction [P<or=.01] in at least 2 regions). The spermine/spermidine N(1)-acetyltransferase gene (SSAT) was successfully validated by reverse transcription-polymerase chain reaction, immunohistochemistry, and Western blot analyses. A variant located in the SSAT polyamine-responsive element regulatory region (SSAT342A/C) demonstrated a significant effect of genotype on SSAT brain expression levels (F(1) = 5.34; P = .02). Further investigation of this variant in an independent sample of 181 male suicide completers and 80 male controls showed a higher frequency of the SSAT342C allele among suicide cases (odds ratio, 2.7; 95% confidence interval, 1.4-5.3; P = .005), suggesting that this allele may increase predisposition to suicide.
CONCLUSIONS: These data suggest a role for SSAT, the rate-limiting enzyme in the catabolism of polyamines, in suicide and depression and a role for the SSAT342 locus in the regulation of SSAT gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389195     DOI: 10.1001/archpsyc.63.1.35

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  68 in total

Review 1.  Suicide and the polyamine system.

Authors:  Jeffrey A Gross; Gustavo Turecki
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-11       Impact factor: 4.388

Review 2.  Current status of the polyamine research field.

Authors:  Anthony E Pegg; Robert A Casero
Journal:  Methods Mol Biol       Date:  2011

3.  Evidence of altered polyamine concentrations in cerebral cortex of suicide completers.

Authors:  Gary Gang Chen; Laura M Fiori; Luc Moquin; Alain Gratton; Orval Mamer; Naguib Mechawar; Gustavo Turecki
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

Review 4.  Targets of polyamine dysregulation in major depression and suicide: Activity-dependent feedback, excitability, and neurotransmission.

Authors:  Agenor Limon; Firoza Mamdani; Brooke E Hjelm; Marquis P Vawter; Adolfo Sequeira
Journal:  Neurosci Biobehav Rev       Date:  2016-04-22       Impact factor: 8.989

5.  A molecular signature of depression in the amygdala.

Authors:  Etienne Sibille; Yingjie Wang; Jennifer Joeyen-Waldorf; Chris Gaiteri; Alexandre Surget; Sunghee Oh; Catherine Belzung; George C Tseng; David A Lewis
Journal:  Am J Psychiatry       Date:  2009-07-15       Impact factor: 18.112

6.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.

Authors:  Firoza Mamdani; Marcelo T Berlim; Marie-Martine Beaulieu; Gustavo Turecki
Journal:  World J Biol Psychiatry       Date:  2013-03-26       Impact factor: 4.132

7.  Fatty acid composition in postmortem brains of people who completed suicide.

Authors:  Aleksandra Lalovic; Emile Levy; Lilian Canetti; Adolfo Sequeira; Alain Montoudis; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

8.  Altered gene synchrony suggests a combined hormone-mediated dysregulated state in major depression.

Authors:  Chris Gaiteri; Jean-Philippe Guilloux; David A Lewis; Etienne Sibille
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

Review 9.  Gene expression studies in major depression.

Authors:  Divya Mehta; Andreas Menke; Elisabeth B Binder
Journal:  Curr Psychiatry Rep       Date:  2010-04       Impact factor: 5.285

10.  Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Authors:  Adolfo Sequeira; Firoza Mamdani; Carl Ernst; Marquis P Vawter; William E Bunney; Veronique Lebel; Sonia Rehal; Tim Klempan; Alain Gratton; Chawki Benkelfat; Guy A Rouleau; Naguib Mechawar; Gustavo Turecki
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.